News & Events
-
Public Calendar: August 27-31, 2012
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
| August 27-31, 2012 | |||||
| FDA Official and Title | Date | Location | Other FDA Participants | Non-FDA Participants | Subject |
|---|---|---|---|---|---|
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 8/27/31- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| John M. Taylor, III, J.D., Counselor to the Commissioner | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Dara A. Corrigan, Associate Commissioner for Regulatory Affairs | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Virginia Cox, Associate Commissioner for External Affairs | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Elizabeth H. Dickinson, Esq., Chief Counsel | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning | 8/29/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine | 8/30/12 | Rockville, MD | William Flynn, Diane Heinz | Dorothy Gray, Tristan Colonius, Donald Hoenig, Kaylee Myhre (American Veterinary Medical Association) | Center for Veterinary Medicine Overview |
| Jesse Goodman, M.D., M.P.H., Chief Scientist | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Michael M. Landa, Director, Center for Food Safety and Applied Nutrition | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Walter Harris, Chief Operating Officer | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Jeanne Ireland, Associate Commissioner for Legislation | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health | 8/28/12 | Silver Spring, MD | Courtney Lias, Carol Benson, Stayce Beck, Arleen Pinkos, Alberto Gutierrez, William Maisel | Patricia Shrader, Mark O'Donnell, Katie Szyman, Fran Kaufman, John Mastrototaro, Chip Zimliki (Medtronic) | Artificial Pancreas |
| William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco | 8/29/12 | Silver Spring, MD | Dianne Murphy, Robert Nelson | Andrew Emmett, Andy Womack (BIO); Janet Jenkins-Showalter (Genentech Roche); Chin Koemer (Novartis); Ron Portman (Bristol-Myers Squibb); AJ Allen (Eli Lilly); Sam Maldonado (Johnson & Johnson) | ICH Guideline, "Clinical Investigation of Medicinal Products in the Pediatric Population, E-11" |
| Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Mary Lou Valdez, Associate Commissioner for International Programs | 8/28/12- 8/29/12 | Washington, DC | N/A | Several representatives from the Pan American Health Organization (PAHO) | 5 year Strategic Plan for Drug Regulatory Authorities |
| Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs | 8/27/12- 8/31/12 | N/A | N/A | N/A | No Significant Meetings |
| Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research | 8/28/12 | Silver Spring, MD | Lisa LaVange, Edward Cox | David Fiedland (Cerexa, INC); Danny Benjamin (Duke University); John Tomyako (GlaxoSmithKline) | Brookings Council on Antibacterial Drug Development |
-
-
